In light of the ONTARGET study, there is no role for the use of ACEi and ARBs in the management of uncomplicated hypertension. There may be a role for this combination in patients with heavy proteinuria (>1-3 grams/day) and the results of the NEPHRON-D study (see link below) should shed light on whether this is true.